Related Experiment Video
Updated: Mar 23, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Monte Carlo dosimetric parameter study of a new (32)P brachytherapy source
Junxiang Wu1, Jing Huang1, Fengxiang Long1
11 Key Laboratory of Radiation Physics and Technology of Ministry of Education, Institute of Nuclear Science and Technology, Sichuan University, Chengdu, Sichuan, China.
A new phosphorus-32 ((32)P) brachytherapy source was developed for liver cancer treatment. Dosimetric data, including dose rate and radial dose function, were calculated using Geant4 Monte Carlo simulations, showing good agreement with existing data.
Area of Science:
- Medical Physics
- Nuclear Medicine
- Radiotherapy
Background:
- A novel catheter-based phosphorus-32 ((32)P) brachytherapy source has been developed for high-dose-rate afterloading applications.
- This source is intended for the treatment of liver cancer, a significant clinical need.
Purpose of the Study:
- To present comprehensive dosimetric data for the new (32)P brachytherapy source.
- To validate the source's characteristics using the Geant4 Monte Carlo (MC) simulation toolkit.
- To provide data essential for clinical implementation and treatment planning.
Main Methods:
- The (32)P source, with dimensions 0.50 cm length and 0.08 cm diameter, encapsulated in Teflon, was simulated.
- Geant4 MC code was employed to calculate absorbed dose within a 30-cm radius water phantom.
- Dosimetric data were generated following the formalism of AAPM TG60 and TG149.
Main Results:
- Key dosimetric data including reference absorbed dose rate, radial dose function (0.10-0.50 cm), and anisotropy function (θ: 0-90°, r: 0.10-0.35 cm) were determined.
- The dose rate at the reference point for the unsheathed (32)P source was calculated as 1.2660 ± 0.0006 cGy s⁻¹ mCi⁻¹.
- The calculated radial dose function showed good agreement with other (32)P sources, with an average difference of 1.78%.
Conclusions:
- Essential dosimetric data for the new (32)P brachytherapy source have been successfully generated.
- These data are crucial for the integration of this new source into clinical treatment-planning systems.
- The study provides foundational information for the safe and effective use of this novel brachytherapy source in liver cancer treatment.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019